SpyGlass Pharma, Inc.
SGP
Last
$24.92
Day
+1.2%
1y
+1.2%
5y
+27.8%
52w
-24.1%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-0525d
EMA 21
26.09
EMA 50
25.75
EMA 200
24.40
20d high
-17.8%
5y high
-27.2%
5y range
58th
Positions held
Your positionsSGP isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
12
Hold
watch
Signal
Neutral
Target
$28.99
Stop
$22.44
Stop distance
9.9%
Target vs last
+16.3%
Fundamentals
| Market cap | $823.49M | Enterprise value | $590.94M | Trailing P/E | — | Forward P/E | -9.06 |
| PEG | — | Price / book | 3.54 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | — | ROA | — | Debt / equity | 0.01 |
| Current ratio | 25.06 | Free cash flow | — | Analyst recommendation | strong_buy | Mean target | $44.00 |
| 52w high | $32.44 | 52w low | $17.06 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$19.9M | -$13.8M | -$12.6M | -$9.8M | -$8.7M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$22.0M | -$15.4M | -$13.6M | -$11.1M | -$9.3M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M |
| Op margin | — | — | — |
| Net income | -$39.9M | -$29.2M | -$13.3M |
| Gross margin | — | — | — |
| Gross profit | — | — | — |
| Operating income | -$41.4M | -$27.1M | -$14.2M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-01 · SpyGlass Pharma Acquires Advanced Vision Science for $13 Million
2026-09-02 · SpyGlass Pharma to Participate in Upcoming Investor Conferences
2026-08-14 · Raymond James Initiates SpyGlass Pharma at Outperform, With $39 Price Target
2026-08-06 · SpyGlass Pharma Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
Price (daily)
Full chart · RSI · MACD · patternsSGP · daily-14.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin